-
Drugs
-
Individual Product Bioequivalence Recommendations: Active Ingredients Starting with 'O'
Individual Product Bioequivalence Recommendations Arranged by Active Ingredient
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
| Active Ingredient (link to Specific Guidance) |
Type | Route of Administration | Dosage Form | RLD Application Number (link to Orange Book) |
Date Recommended |
|---|---|---|---|---|---|
| Olanzapine | Draft | Oral | Tablet | 20592 | 8/2008 |
| Olanzapine | Final | Oral | Tablet, Orally Disintegrating | 21086 | 5/2008 |
| Olmesartan Medoxomil | Final | Oral | Tablet | 21286 | 5/2008 |
| Olopatadine HCl | Draft | Ophthalmic | Solution | 9/2008 | |
| Olsalazine Sodium | Final | Oral | Capsule | 19715 | 5/2008 |
| Omeprazole | Final | Oral | Capsule, Delayed Release | 19810 | 5/2008 |
| Omeprazole Magnesium | Final | Oral | Tablet, Delayed Release | 21229 | 5/2008 |
| Omeprazole; Sodium Bicarbonate | Draft | Oral | Capsule | 21849 | 7/2008 |
| Omeprazole; Sodium Bicarbonate Revised |
Draft | Oral | Suspension | 21636 | 7/2009 |
| Omeprazole, Sodium Bicarbonate; Magnesium Hydroxide | Draft | Oral | Tablet, Chewable | 21850 | 2/2008 |
| Ondansetron | Final | Oral | Tablet, Orally Disintegrating | 20781 | 5/2008 |
| Ondansetron HCl | Final | Oral | Tablet | 20103 | 5/2008 |
| Oxcarbazepine | Final | Oral | Suspension | 21285 | 5/2008 |
| Oxcarbazepine | Final | Oral | Tablet | 21014 | 5/2008 |
| Oxybutynin Chloride | Draft | Oral | Tablet, Extended Release | 20897 | 3/2009 |
| Oxymorphone HCl | Draft | Oral | Tablet | 21611 | 1/2008 |
| Oxymorphone HCl | Draft | Oral | Tablet, Extended Release | 21610 | 11/2007 |
-
-